Bortezomib and rituximab in multiply relapsed primary warm autoimmune hemolytic anemia. Ames PRJ, Jeffrey S. Ann Hematol 2020 Jun 17. pii: 10.1007/s00277-020-04135.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ames PRJ, Jeffrey S. Bortezomib and rituximab in multiply relapsed primary warm autoimmune hemolytic anemia. Ann Hematol 2020 Jun 17. pii: 10.1007/s00277-020-04135.
PMID: 32548660